As we forge ahead in the behavioral health field, finding the right balance between technological solutions and whole-person care will be essential. Workforce challenges, changes to the way reimbursements work, new medication monitoring options and a laser focus on the personalized solutions that specialty pharmacies can provide are all trends to watch.
Cano Health filed for bankruptcy this week about three years after going public $4.4 billion SPAC merger. The industry reacted without surprise, with experts calling the bankruptcy a direct result of mismanagement, a quixotic growth strategy and poor market selection.
Companion care company Papa has created two programs for health plans: one that addresses social drivers of health and one that aims to improve health plans' star ratings.
Cell therapies were first validated in cancer, but Kyverna Therapeutics aims to show they’re safe enough for autoimmune diseases. The biotech plans to deploy its IPO cash across clinical trials in lupus nephritis, multiple sclerosis, systemic sclerosis, and myasthenia gravis.